Vimarsana
Biggest News Aggregation in the World

Page 17 - Intern Med News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Intern Med. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Intern Med Today - Breaking & Trending Today

Sodium bicarbonate for kidney transplant recipients with metabolic acidosis in Switzerland: a multicentre, randomised, single-blind, placebo-controlled, phase 3 trial - Vimarsana News

Sodium bicarbonate for kidney transplant recipients with metabolic acidosis in Switzerland: a multicentre, randomised, single-blind, placebo-controlled, phase 3 trial

In adult kidney transplant recipients, correction of metabolic acidosis by treatment with sodium bicarbonate over 2 years did not affect the decline in estimated GFR. Thus, treatment with sodium bicarbonate should not be generally recommended to preserve estimated GFR (a surrogate marker for graft function) in kidney transplant recipients with chronic kidney disease who have metabolic acidosis.

Shionogi's Innovative Antibiotic, FETCROJA (cefiderocol), Is Now Available in Norway - Vimarsana News

Shionogi's Innovative Antibiotic, FETCROJA (cefiderocol), Is Now Available in Norway

FOR NORWEGIAN MEDICAL AND PHARMA TRADE MEDIA AND PROFESSIONAL SOCIETIES ONLY Following local reimbursement by the Norwegian Medicines Agency (Legemiddelverket), FETCROJA(cefiderocol) is now available

Institutional collusion and corruption runs DEEP – Prof Noakes on Keys' Cholesterol Con - Vimarsana News

Institutional collusion and corruption runs DEEP – Prof Noakes on Keys' Cholesterol Con

Perhaps the most shocking article in the Cholesterol Con series, Part Twelve details the depths of institutional collusion and corruption.

Cardiovascular risk in systemic autoimmune diseases - Vimarsana News

Cardiovascular risk in systemic autoimmune diseases

In a large population-based observational study, Nathalie Conrad and colleagues1 showed the association between 19 autoimmune diseases and 12 cardiovascular diseases (CVDs) with data from about 22 000 000 people in the UK. However, we are concerned about the possibly confusing message caused by treating several CVDs as a composite outcome in this study.

Machine learning-based marker for coronary artery disease: derivation and validation in two longitudinal cohorts - Vimarsana News

Machine learning-based marker for coronary artery disease: derivation and validation in two longitudinal cohorts

Electronic health record-based machine learning was used to generate an in-silico marker for coronary artery disease that can non-invasively quantify atherosclerosis and risk of death on a continuous spectrum, and identify underdiagnosed individuals.